Histopathological evaluation of liver fibrosis and cirrhosis regression
Regina C. Lo, Haeryoung Kim
Clin Mol Hepatol. 2017;23(4):302-307.   Published online 2017 Dec 20     DOI: https://doi.org/10.3350/cmh.2017.0078
Citations to this article as recorded by Crossref logo
The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis
Suhyun Park, Seon In Hwang, Jonghun Kim, Seoyeon Hwang, Sohee Kang, Sera Yang, Jonghwa Kim, Wonseok Kang, Kyun-Hwan Kim, Dong Wook Han, Yong-Han Paik
Stem Cell Research & Therapy.2019;[Epub]     CrossRef
Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation
Weiwei Chen, Zili Zhang, Zhen Yao, Ling Wang, Feng Zhang, Jiangjuan Shao, Anping Chen, Shizhong Zheng
International Immunopharmacology.2018; 56: 148.     CrossRef
The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation
Li Li, Jie Zhou, Qiufang Li, Jianjun Xu, Jing Qi, Hua Bian
Biomedicine & Pharmacotherapy.2018; 106: 83.     CrossRef
The role of chemerin and vaspin in Egyptian patients with viral hepatitis C
Shawkey Ali, Doha Ellakwa, Sally Emara, Noha El-Sabbagh
Meta Gene.2018; 18: 23.     CrossRef
Magnetic resonance elastography of healthy livers at 3.0 T: Normal liver stiffness measured by SE-EPI and GRE
Jae Seok Bae, Jeong Min Lee, Sae-Jin Park, Kyung Bun Lee, Joon Koo Han
European Journal of Radiology.2018; 107: 46.     CrossRef